Lysinenorleucine
featured

Orders received during 11/25~11/29 will be shipped in 11/30/2020 due to Thanksgiving holiday.

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 597574

CAS#: 25612-46-8

Description: Lysinenorleucine s a Lysine and hydroxylysine derivatives for treatment of malignant and benign tumors.


Price and Availability

Size Price Shipping out time Quantity
5mg USD 60 2 Weeks
10mg USD 1210 2 Weeks
25mg USD 2625 2 Weeks
Inquire bulk and customized quantity

Pricing updated 2020-11-29. Prices are subject to change without notice.

Lysinenorleucine, purity > 98%, is in stock. Current shipping out time is about 2 weeks after order is received. CoA, QC data and MSDS documents are available in one week after order is received.


Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 597574
Name: Lysinenorleucine
CAS#: 25612-46-8
Chemical Formula: C12H25N3O4
Exact Mass: 275.1845
Molecular Weight: 275.34
Elemental Analysis: C, 52.35; H, 9.15; N, 15.26; O, 23.24


Synonym: Lysinenorleucine; Lys-nle;

IUPAC/Chemical Name: (2S,2'S)-6,6'-azanediylbis(2-aminohexanoic acid)

InChi Key: HYLBTMZBXLEVCL-UWVGGRQHSA-N

InChi Code: InChI=1S/C12H25N3O4/c13-9(11(16)17)5-1-3-7-15-8-4-2-6-10(14)12(18)19/h9-10,15H,1-8,13-14H2,(H,16,17)(H,18,19)/t9-,10-/m0/s1

SMILES Code: N[C@@H](CCCCNCCCC[C@H](N)C(O)=O)C(O)=O


Technical Data

Appearance:
Solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO

Shelf Life:
>3 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code:
2934.99.03.00


References

1: van den Nieuwendijk AM, Benningshof JC, Wegmann V, Bank RA, te Koppele JM, Brussee J, van der Gen A. Synthesis of reduced collagen crosslinks. Bioorg Med Chem Lett. 1999 Jun 21;9(12):1673-6. PubMed PMID: 10397498.

2: Nakamura Y, Okamoto K, Tanimura A, Kato M, Morimatsu M. Elastase digestion and biochemical analysis of the elastin from an elastofibroma. Cancer. 1986 Sep 1;58(5):1070-5. PubMed PMID: 3637115.

3: Nielsen CJ, Bentley JP, Marshall FJ. Age-related changes in reducible crosslinks of human dental pulp collagen. Arch Oral Biol. 1983;28(8):759-64. PubMed PMID: 6579908.

4: Liu Y, Springer IN, Zimmermann CE, Açil Y, Scholz-Arens K, Wiltfang J, Terheyden H. Missing osteogenic effect of expanded autogenous osteoblast-like cells in a minipig model of sinus augmentation with simultaneous dental implant installation. Clin Oral Implants Res. 2008 May;19(5):497-504. doi: 10.1111/j.1600-0501.2007.01504.x. Epub 2008 Mar 26. PubMed PMID: 18371097.

5: Levene CI, Heale G, Robins SP. Collagen cross-link synthesis in cultured vascular endothelium. Br J Exp Pathol. 1989 Dec;70(6):621-6. PubMed PMID: 2605112; PubMed Central PMCID: PMC2040723.

6: Richmond VL. The microfibrillar components of porcine lung elastic fiber. Biochim Biophys Acta. 1981 Jul 28;669(2):193-205. PubMed PMID: 7197163.

7: Konieczny L, Piekarska B, Rybarska J, Stopa B, Krzykwa B, Noworolski J, Pawlicki R, Roterman I. Bis azo dye liquid crystalline micelles as possible drug carriers in immunotargeting technique. J Physiol Pharmacol. 1994 Sep;45(3):441-54. PubMed PMID: 7841456.